Last A$67.35 AUD
Change Today +0.20 / 0.30%
Volume 1.2M
CSL On Other Exchanges
As of 2:10 AM 07/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gordon Naylor MBA, BEng (Hons), Dipcompsc

Chief Financial Officer, CSL Ltd.
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Gordon Naylor has been the Chief Financial Officer of CSL Biotherapies, Inc. since January 1, 2009 and Chief Financial Officer of CSL Ltd since October 2010. Mr. Naylor serves as the Chief Financial Officer at CSL Behring LLC. Mr. Naylor served as the Chief Information Officer at CSL Behring LLC. He served as Executive Vice President of Plasma & Supply Chain at CSL Behring LLC. He served as an Executive Vice President of Plasma, Supply Chain & Information Systems ...

Read Full Background

Corporate Headquarters*

45 Poplar Road
Parkville, Victoria 3052


Phone: 61 3 9389 1911
Fax: 61 3 9389 1434

Board Members Memberships*



Unknown/Other Education
The University of Melbourne
Bachelor's Degree
The University of Melbourne
The University of Melbourne
Melbourne Business School in the University of Melbourne

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,542,900

Stock Options*

Restricted Stock Awards$560,383
All Other Compensation$146,950
Exercisable Options32,720
Unexercisable Options61,860
Total Number of Options94,580

Total Compensation*

Total Annual Cash Compensation$1,689,850
Total Short Term Compensation$1,542,900
Other Long Term Compensation$707,333
Total Calculated Compensation$2,374,836
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CSL:AU A$67.35 AUD +0.20


Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
Victor Grifols Roura Chairman, Chief Executive Officer, President, Managing Director and Member of Appointments & Remuneration Committee
Grifols, S.A.
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CSL LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at